Altice USA climbs after report of buyout interest for Altice's Portuguese operations Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Enveric Biosciences (ENVB) up 11% after announcing that it has named EB-003 as its lead drug candidate from the company's next-generation EVM301 Series
- Altice USA (ATUS) up 6% after Bloomberg reported billionaire Xavier Niel has expressed interest in buying the Portuguese operations of Altice
- Penn Entertainment (PENN) up 3% after HG Vora Capital Management disclosed that they hold the economic equivalent of an 18.5% position in Penn Entertainment's common stock and requested the company afford them the right to designate directors
LOWER -
- Bluejay Diagnostics (BJDX) down 32% after pricing 2.69M shares at $1.30 in a public offering
- CytoSorbents (CTSO) down 34% after reporting its STAR-T trial did not meet the primary effectiveness endpoint
- Velo3D (VLD) down 23% after selling 36M shares at 50c per share in a registered direct offering
Symbols:
ENVB ATUS PENN VLD CTSO BJDX Keywords: Fly Intel, Wall Street, Top Stories, Stocks